- Home
- MYO vs SGMO Comparison
MYO vs SGMO Comparison
Compare MYO & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYO
- SGMO
- Stock Information
- Founded
- MYO 2004
- SGMO 1995
- Country
- MYO United States
- SGMO United States
- Employees
- MYO N/A
- SGMO N/A
- Industry
- MYO Industrial Specialties
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MYO Health Care
- SGMO Health Care
- Exchange
- MYO Nasdaq
- SGMO Nasdaq
- Market Cap
- MYO 153.0M
- SGMO 122.8M
- IPO Year
- MYO 2017
- SGMO 2000
- Fundamental
- Price
- MYO $1.99
- SGMO $0.56
- Analyst Decision
- MYO Strong Buy
- SGMO Buy
- Analyst Count
- MYO 3
- SGMO 6
- Target Price
- MYO $9.67
- SGMO $4.50
- AVG Volume (30 Days)
- MYO 458.1K
- SGMO 5.7M
- Earning Date
- MYO 08-08-2025
- SGMO 08-05-2025
- Dividend Yield
- MYO N/A
- SGMO N/A
- EPS Growth
- MYO N/A
- SGMO N/A
- EPS
- MYO N/A
- SGMO N/A
- Revenue
- MYO $38,628,624.00
- SGMO $63,756,000.00
- Revenue This Year
- MYO $55.29
- SGMO $1.29
- Revenue Next Year
- MYO $27.18
- SGMO $1.60
- P/E Ratio
- MYO N/A
- SGMO N/A
- Revenue Growth
- MYO 97.60
- SGMO 239.92
- 52 Week Low
- MYO $1.85
- SGMO $0.41
- 52 Week High
- MYO $7.17
- SGMO $3.18
- Technical
- Relative Strength Index (RSI)
- MYO 33.51
- SGMO 56.85
- Support Level
- MYO $1.85
- SGMO $0.50
- Resistance Level
- MYO $2.20
- SGMO $0.70
- Average True Range (ATR)
- MYO 0.14
- SGMO 0.04
- MACD
- MYO 0.04
- SGMO 0.01
- Stochastic Oscillator
- MYO 23.36
- SGMO 43.43
About MYO Myomo Inc.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.